When administered subcutaneously once a week, semaglutide significantly and meaningfully reduces weight, along with lifestyle interventions such as increased physical activity and reduced calorie intake
Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans Proven weight loss, the affordable way Up to 15-20% weight loss with Wegovy and Zepbound* Affordable GLP-1s, delivered fast** Covered by top insurance plans *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) and Zepbound (15 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
For intensive care, apply a thicker layer before bed
Wegovy: Titrated to 2.4 mg weekly
Complicated UTIs, including kidney infections with systemic symptoms, present a different scenario